HIV-1 genetic variation and drug resistance development.
about
Potential Antiviral Agents from Marine Fungi: An OverviewResistance analyses of integrase strand transfer inhibitors within phase 3 clinical trials of treatment-naive patients.The impact of wild-type reversion on transmitted resistance surveillance.Designer antigens for elicitation of broadly neutralizing antibodies against HIV.Potent in vitro antiviral activity of Cistus incanus extract against HIV and Filoviruses targets viral envelope proteins.Antifungal and antiviral products of marine organisms.Drug resistance in the HIV-1-infected paediatric population worldwide: a systematic review.HIV-1 Subtype Diversity and Prevalence of Primary Drug Resistance in a Single-Center Pediatric Cohort in Germany.Polyhydroxylated sulfated steroids derived from 5α-cholestanes as antiviral agents against herpes simplex virus.
P2860
Q26800107-AA067EE0-3C95-4DCA-891A-C93A2744F706Q33963458-87426507-DFC9-4D1F-868C-54C13C8A71D0Q34054047-3963A529-A948-4C6D-9745-FEFED7C83CD9Q34511575-78D82473-D413-4658-991C-356A3B4478FFQ36528651-FCFD7867-A5D5-4782-94DC-895D0B7FBFA6Q37634178-12108D07-89AE-48BC-B1F6-4CFC3FF6F156Q38208721-D58C1506-4D96-46EC-9EF6-A8000163729FQ38694328-1F2503E7-DA07-458F-90E3-A5840B9A767CQ38776533-FC0925B2-A977-4A39-8698-9280CC873C8E
P2860
HIV-1 genetic variation and drug resistance development.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
HIV-1 genetic variation and drug resistance development.
@ast
HIV-1 genetic variation and drug resistance development.
@en
type
label
HIV-1 genetic variation and drug resistance development.
@ast
HIV-1 genetic variation and drug resistance development.
@en
prefLabel
HIV-1 genetic variation and drug resistance development.
@ast
HIV-1 genetic variation and drug resistance development.
@en
P2860
P1476
HIV-1 genetic variation and drug resistance development.
@en
P2093
Sarah Megens
P2860
P304
P356
10.1586/14787210.2013.844649
P577
2013-11-01T00:00:00Z